Third, although we were unable to account for the effect of CpG island methylator phenotype (CIMP), MSI status, and mutations such as BRAF due to lack of available information, which are known to affect CRC prognosis, studies have suggested that adjustment of these factors had little impact on the associations 18, 25. This evidence concerns the gene BRAF and colorectal carcinoma.